SAN DIEGO, July 30, 2021 (GLOBE NEWSWIRE) — Johnson Fistel, LLP is investigating potential claims on behalf of Emergent BioSolutions Inc. (“Emergent” or the “Company”) (NYSE: EBS) against certain of its officers and directors.

By A Silva